|
業務類別
|
Biotechnology |
|
業務概覽
|
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others. |
| 公司地址
| 2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608 |
| 電話號碼
| +1 510 204-7200 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.xoma.com |
| 員工數量
| 13 |
| Mr. Bradley Sitko |
Chief Investment Officer |
美元 520.00K |
15/04/2025 |
| Mr. Jeffrey Trigilio |
Chief Financial Officer |
-- |
15/01/2026 |
| Mr. Owen P. Hughes, Jr |
Chief Executive Officer and Director |
美元 566.48K |
15/04/2025 |
|
|
| Mr. Jack L. Wyszomierski, M.S. |
Chairman of the Board |
15/04/2025 |
| Ms. Heather L. Franklin |
Independent Director |
15/04/2025 |
| Mr. Joseph M. Limber |
Independent Director |
15/04/2025 |
| Mr. Matthew D. Perry |
Independent Director |
15/04/2025 |
| Mr. Owen P. Hughes, Jr |
Chief Executive Officer and Director |
15/04/2025 |
| Ms. Barbara Kosacz, J.D. |
Independent Director |
15/04/2025 |
| Ms. Natasha A. Hernday |
Independent Director |
15/04/2025 |
|
|
|
|
